Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents.
Saved in:
| Title: | Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents. |
|---|---|
| Authors: | Gobbo M; Unit of Oral and Maxillofacial Surgery, Ca' Foncello Hospital, Piazzale Ospedale, Treviso, Italy., Joy J; Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA, USA., Guedes H; Medical Oncology Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Porto, Portugal., Shazib MA; Workman School of Dental Medicine, High Point University, High Point, NC, USA., Anderson C; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, USA., Abdalla-Aslan R; Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa, Israel.; Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel., Peechatanan K; Supportive and Palliative Care Unit, Monash Health, Clayton, VIC, Australia.; Department of Medicine, Division of Medical Oncology, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand., Lajolo C; Head and Neck Department, Fondazione Policlinico Universitario A. Gemelli-IRCCS, School of Dentistry, Università Cattolica del Sacro Cuore, Rome, Italy., Nasir KS; Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Gueiros LA; Department of Clinic and Preventive Dentistry & Oral Medicine Unit, Health Sciences Center, Hospital das Clínicas, Federal University of Pernambuco, Recife, Brazil., Nagarajan N; Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, California, USA., Hafezi Motlagh K; Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran., Kandwal A; Himalayan Institute of Medical Sciences Cancer Research Institute Swami Rama Himalayan University, Uttarakhand, India., Rupe C; Head and Neck Department, Fondazione Policlinico Universitario A. Gemelli-IRCCS, School of Dentistry, Università Cattolica del Sacro Cuore, Rome, Italy., Xu Y; Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, MA, USA., Ehrenpreis ED; Department of Medicine, Advocate Lutheran General Hospital, Park Ridge, IL, USA.; E2Bio Life Sciences, Skokie, IL, USA., Tonkaboni A; Oral Medicine Department, School of Dentistry, Tehran University of Medical Science, Tehran, Iran., Epstein JB; Department of Surgery, City of Hope National Cancer Center, Duarte, CA, USA., Bossi P; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Wardill HR; School of Biomedicine, The University of Adelaide, Adelaide, Australia.; Supportive Oncology Research Group, Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia., Graff SL; Lifespan Cancer Institute, Providence, RI, USA.; Legorreta Cancer Center, Brown University, Providence, RI, USA. |
| Source: | Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Apr; Vol. 25 (6), pp. 727-742. Date of Electronic Publication: 2024 May 29. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-7666 |
|---|---|
| DOI: | 10.1080/14656566.2024.2354451 |
